Annual Operating Profit
-$155.56 M
+$23.94 M+13.34%
31 December 2023
Summary:
Esperion Therapeutics annual operaing income is currently -$155.56 million, with the most recent change of +$23.94 million (+13.34%) on 31 December 2023. During the last 3 years, it has fallen by -$34.17 million (-28.15%). ESPR annual operating profit is now -1430.47% below its all-time high of -$10.16 million, reached on 31 December 2011.ESPR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$16.03 M
-$18.61 M-721.40%
30 September 2024
Summary:
Esperion Therapeutics quarterly operating income is currently -$16.03 million, with the most recent change of -$18.61 million (-721.40%) on 30 September 2024. Over the past year, it has increased by +$11.51 million (+41.79%). ESPR quarterly operating profit is now -112.41% below its all-time high of $129.17 million, reached on 30 June 2020.ESPR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$16.45 M
+$11.51 M+232.56%
30 September 2024
Summary:
Esperion Therapeutics TTM operating income is currently $16.45 million, with the most recent change of +$11.51 million (+232.56%) on 30 September 2024. Over the past year, it has increased by +$172.16 million (+110.57%). ESPR TTM operating profit is now at all-time high.ESPR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.3% | +41.8% | +110.6% |
| 3 y3 years | -28.1% | +71.3% | +106.2% |
| 5 y5 years | +24.0% | +75.6% | +117.4% |
ESPR Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.1% | +31.4% | -122.2% | +71.3% | at high | +106.2% |
| 5 y | 5 years | -67.1% | +31.4% | -112.4% | +83.2% | at high | +105.7% |
| alltime | all time | -1430.5% | +31.4% | -112.4% | +83.2% | at high | +105.7% |
Esperion Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.03 M(-721.4%) | $16.45 M(+232.6%) |
| June 2024 | - | $2.58 M(-96.4%) | $4.95 M(-114.3%) |
| Mar 2024 | - | $72.27 M(-270.6%) | -$34.69 M(-77.7%) |
| Dec 2023 | -$155.56 M(-13.3%) | -$42.37 M(+53.9%) | -$155.56 M(-0.1%) |
| Sept 2023 | - | -$27.53 M(-25.7%) | -$155.71 M(-8.3%) |
| June 2023 | - | -$37.06 M(-23.8%) | -$169.80 M(-8.3%) |
| Mar 2023 | - | -$48.60 M(+14.3%) | -$185.12 M(+3.1%) |
| Dec 2022 | -$179.50 M(-20.8%) | -$42.51 M(+2.1%) | -$179.50 M(-6.8%) |
| Sept 2022 | - | -$41.62 M(-20.5%) | -$192.62 M(-6.8%) |
| June 2022 | - | -$52.38 M(+21.8%) | -$206.74 M(+10.6%) |
| Mar 2022 | - | -$42.99 M(-22.7%) | -$186.90 M(-17.6%) |
| Dec 2021 | -$226.73 M(+86.8%) | -$55.63 M(-0.2%) | -$226.73 M(-15.0%) |
| Sept 2021 | - | -$55.74 M(+71.3%) | -$266.67 M(-8.5%) |
| June 2021 | - | -$32.53 M(-60.7%) | -$291.48 M(+124.6%) |
| Mar 2021 | - | -$82.82 M(-13.3%) | -$129.77 M(+6.9%) |
| Dec 2020 | -$121.40 M(+30.4%) | -$95.57 M(+18.6%) | -$121.40 M(+43.2%) |
| Sept 2020 | - | -$80.55 M(-162.4%) | -$84.79 M(+21.1%) |
| June 2020 | - | $129.17 M(-273.5%) | -$70.01 M(-72.5%) |
| Mar 2020 | - | -$74.45 M(+26.3%) | -$254.48 M(+173.3%) |
| Dec 2019 | -$93.10 M(-54.5%) | -$58.96 M(-10.3%) | -$93.10 M(-1.8%) |
| Sept 2019 | - | -$65.77 M(+18.9%) | -$94.79 M(+19.1%) |
| June 2019 | - | -$55.30 M(-163.6%) | -$79.58 M(+12.5%) |
| Mar 2019 | - | $86.93 M(-243.3%) | -$70.76 M(-65.4%) |
| Dec 2018 | -$204.59 M(+21.1%) | -$60.65 M(+19.9%) | -$204.59 M(+12.0%) |
| Sept 2018 | - | -$50.56 M(+8.8%) | -$182.63 M(+2.7%) |
| June 2018 | - | -$46.48 M(-0.9%) | -$177.81 M(+1.6%) |
| Mar 2018 | - | -$46.89 M(+21.2%) | -$174.99 M(+3.6%) |
| Dec 2017 | -$168.98 M | -$38.70 M(-15.4%) | -$168.98 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$45.74 M(+4.8%) | -$159.57 M(+21.3%) |
| June 2017 | - | -$43.66 M(+6.8%) | -$131.55 M(+28.7%) |
| Mar 2017 | - | -$40.89 M(+39.6%) | -$102.22 M(+34.2%) |
| Dec 2016 | -$76.15 M(+52.2%) | -$29.29 M(+65.3%) | -$76.15 M(+26.7%) |
| Sept 2016 | - | -$17.71 M(+23.6%) | -$60.10 M(+8.7%) |
| June 2016 | - | -$14.33 M(-3.3%) | -$55.31 M(+3.5%) |
| Mar 2016 | - | -$14.82 M(+12.0%) | -$53.44 M(+6.8%) |
| Dec 2015 | -$50.04 M(+38.1%) | -$13.23 M(+2.4%) | -$50.04 M(+8.3%) |
| Sept 2015 | - | -$12.92 M(+3.7%) | -$46.19 M(+7.5%) |
| June 2015 | - | -$12.46 M(+9.1%) | -$42.97 M(+8.1%) |
| Mar 2015 | - | -$11.43 M(+21.8%) | -$39.76 M(+9.8%) |
| Dec 2014 | -$36.22 M(+59.2%) | -$9.38 M(-3.3%) | -$36.22 M(-1.0%) |
| Sept 2014 | - | -$9.70 M(+4.8%) | -$36.58 M(+13.3%) |
| June 2014 | - | -$9.25 M(+17.3%) | -$32.29 M(+18.2%) |
| Mar 2014 | - | -$7.89 M(-19.0%) | -$27.30 M(+20.0%) |
| Dec 2013 | -$22.76 M(+123.0%) | -$9.74 M(+80.1%) | -$22.76 M(+49.9%) |
| Sept 2013 | - | -$5.41 M(+26.6%) | -$15.18 M(+18.9%) |
| June 2013 | - | -$4.27 M(+27.8%) | -$12.77 M(+12.4%) |
| Mar 2013 | - | -$3.34 M(+54.8%) | -$11.36 M(+11.3%) |
| Dec 2012 | -$10.20 M(+0.4%) | -$2.16 M(-27.8%) | -$10.20 M(+26.9%) |
| Sept 2012 | - | -$2.99 M(+4.4%) | -$8.04 M(+59.2%) |
| June 2012 | - | -$2.86 M(+30.8%) | -$5.05 M(+130.8%) |
| Mar 2012 | - | -$2.19 M | -$2.19 M |
| Dec 2011 | -$10.16 M(-65.2%) | - | - |
| Dec 2002 | -$29.24 M(-0.3%) | - | - |
| Dec 2001 | -$29.33 M(+6.4%) | - | - |
| Dec 2000 | -$27.57 M(+122.9%) | - | - |
| Dec 1999 | -$12.37 M | - | - |
FAQ
- What is Esperion Therapeutics annual operaing income?
- What is the all time high annual operating profit for Esperion Therapeutics?
- What is Esperion Therapeutics annual operating profit year-on-year change?
- What is Esperion Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly operating profit year-on-year change?
- What is Esperion Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Esperion Therapeutics?
- What is Esperion Therapeutics TTM operating profit year-on-year change?
What is Esperion Therapeutics annual operaing income?
The current annual operating profit of ESPR is -$155.56 M
What is the all time high annual operating profit for Esperion Therapeutics?
Esperion Therapeutics all-time high annual operaing income is -$10.16 M
What is Esperion Therapeutics annual operating profit year-on-year change?
Over the past year, ESPR annual operaing income has changed by +$23.94 M (+13.34%)
What is Esperion Therapeutics quarterly operating income?
The current quarterly operating profit of ESPR is -$16.03 M
What is the all time high quarterly operating profit for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly operating income is $129.17 M
What is Esperion Therapeutics quarterly operating profit year-on-year change?
Over the past year, ESPR quarterly operating income has changed by +$11.51 M (+41.79%)
What is Esperion Therapeutics TTM operating income?
The current TTM operating profit of ESPR is $16.45 M
What is the all time high TTM operating profit for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM operating income is $16.45 M
What is Esperion Therapeutics TTM operating profit year-on-year change?
Over the past year, ESPR TTM operating income has changed by +$172.16 M (+110.57%)